초록 ▼

An improved infant formula resulting in reduced constipation, abdominal discomfort and gastrointestinal problems, comprises at least one protein component having a phosphorus content of less than 0.75 g P/100 g protein, and at least one lipid component that can be easily digested by an infant. Prefe

An improved infant formula resulting in reduced constipation, abdominal discomfort and gastrointestinal problems, comprises at least one protein component having a phosphorus content of less than 0.75 g P/100 g protein, and at least one lipid component that can be easily digested by an infant. Preferably, it further comprises at least one prebiotic component, and at least one viscosity-improving component. The protein fraction of the formula is preferably a hydrolysate prepared by hydrolysing a protein starting material, especially a whey protein with a combination of at least one endo- and at least one exoproteinase.

대표청구항 ▼

1. An infant formula comprising:a) a protein component having a phosphorous content of less than 0.75 P100 g protein; and b) a lipid component that can be digested by an infant, comprising fatty acid triglycerides in which palmitic acid residues make up more than 10% of all fatty acid residues prese

1. An infant formula comprising:a) a protein component having a phosphorous content of less than 0.75 P100 g protein; and b) a lipid component that can be digested by an infant, comprising fatty acid triglycerides in which palmitic acid residues make up more than 10% of all fatty acid residues present in the triglycerides, and wherein palmitic acid residues in the Sn1 or Sn3 position make up more then 16% of all triglycerides present. 2. The infant formula according to claim 1, in which the protein component a) has a phosphorus content of less than 0.72 g P/100 g protein, more preferably less than 0.69 g P/100 g protein.3. The infant formula according to claim 1, in which the at least one protein component a) is a hydrolysate obtained by hydrolyzing a starting material comprising proteins from mammalian milk or a dephosphorylated protein from plant origin with a combination of at least one endo- and at least one exoproteinase.4. The infant formula according to claim 3, in which the hydrolysate used as component a) is obtained by hydrolysing a starting material comprising a milk protein, a mixture of milk proteins and/or a milk protein preparation with a combination of at least one endo- and at least one exoproteinase.5. The infant formula according to claim 1, further comprising at least one of: c) at least one prebiotic component, selected from lacto N-tetraose, lacto-N-fuco-pentaose, lactulose, lactosucrose, raffinose, galacto-oligosaccharides, fructo-oligo-saccharides, oligosaccharides derived from soybean polysaccharides, mannose-based oligosaccharides, arabino-oligosaccharides, xylo-oligosaccharides, isomalto-oligo-saccharides, glucas, sialyl oligosaccharides and fuco-oligosaccharides; and d) at least one viscosity-improving component.6. The infant formula according to claim 1, characterised by a content of free amino acids, derived from the protein hydrolysate a), of less than 10 g per 100 g protein equivalent.7. The infant formula according to claim 1, characterised by an osmolality of less than 270 mOsmol/l.8. The infant formula according to claim 1, intended for infants of less than 6 months old, characterised by a calcium content, expressed as mg of calcium per 100 kcal of energy content of the formula, of less than 80 g/100 kcal.9. The infant formula according to claim 1, intended for infants of more than 6 months old, characterised by a calcium content, expressed as mg of calcium per 100 kcal of energy content of the formula, of less than 122 mg/100 kcal.10. The infant formula according to claim 1, characterised by a calcium-to-phosphorus ratio of between 1.4 and 2.11. The infant formula according to claim 1, characterised by an overall fat content, expressed as total lipid content, of between 20 and 45 wt. %.12. The infant formula according to claim 1, characterised by a viscosity of between 20 and 100 cps, as measured in a Brookfield viscosimeter at 30 rpm.13. The infant formula according to claim 1, characterised by a lactose content of at most 6,0 g/100 ml, of the total formula.14. The infant formula according to claim 1, in which at least 30% of the palmitic acid residues in the triglycerides are in the Sn2 position of the triglycerides.15. An infant formula comprising:a) a protein component having a phosphorus content of less than 0.75 g P/100 g protein; and b) a lipid component that can be easily digested by an infant, comprising fatty acid triglycerides in which palmitic acid residues make up more than 10% of all fatty acid residues present in the triglycerides in which the relative amounts of the components are: protein component a):6.4 to 16wt. %one lipid component b):18 to 29wt. %at least one prebiotic component c):0 to 15wt. %at least one viscosity improving component d):0 to 15wt. %further components:0 to 60wt. %to a total of 100 wt. % of the final formula.16. The infant formula according to claim 15, in which:the relative amount of component c) is3.0 to 15 wt. %,and/or the relative amount of component d) is:1.5 to 15 wt. %.17. The infant formula according to claim 15, in which at least 30% of the palmitic acid residue in the triglycerides are in the Sn2 position of the triglycerides.18. An infant formula, comprising a protein hydrolysate of claim 17, further comprising b) at least one lipid component that can be easily digested by an infant.19. A process for preparing a protein hydrolysate, comprising hydrolysing a protein starting material having a phosphorous content of less than 0.75 g P/100 protein with a combination of at least one endo- and at least one exoproteinase in which the starting material further contains a suspension of yeast cells in an amount of 1 to 8 g dry mass of yeast cells per 100 g protein.20. The process according to claim 19, comprising hydrolysing a starting material comprising a milk protein, a mixture of milk proteins and/or a milk protein preparation.21. The process according to claim 20, comprising hydrolysing proteins from mammal milk.22. A protein hydrolysate obtained by the process of claim 19.23. Infant formula, comprising a protein hydrolysate of claim 22.24. Infant formula according to claim 22, further comprisingb) at least one lipid component that can be easily digested by an infant; and optionally one or two of: c) at least one prebiotic component; d) at least one viscosity improving component. 25. A process for preparing a protein hydrolysate, comprising hydrolysing a protein starting material having a phosphorous content of less than 0.75 g P/100 protein with a combination of at least one endo- and at least one exoproteinase in which the combination of the endo- and exoproteinases is a mixture containing endopeptidase from Bacillus lichenformis, trypsin and endo- and exoproteinases from Aspergillus oryzae. 26. A protein hydrolysate obtained by the process of claim 25.27. An infant formula, comprising a protein hydrolysate of claim 26, further comprising b) at leas one lipid component that can be easily digested by an infant.28. A process for preparing a protein hydrolysate, comprising hydrolysing a protein starting material having a phosphorous content of less than 0.75 g P/100 protein with a combination of at east one endo- and at least one exoproteinase in which the hydrolysis is carried out at a temperature between 45 and 60° C., and is terminated by cooling the total hydrolysis mixture from the hydrolysis temperature to a temperature of less than 20° C., over a period of time of 10 m. to 1 hour.29. A protein hydrolysate obtained by the process of claim 28.